The Canadian Partnership for Tomorrow’s Health, hosted by the U of T’s Dalla Lana School of Public Health, has received a $1.9 million to identify individuals who have COVID-19 antibodies (photo by Naveen Sharma/SOPA Images/LightRocket via Getty Images)

Researchers at U of T to study presence of COVID-19 antibodies in high-?risk populations

Posted on

The Canadian Partnership for Tomorrow’s Health (CanPath), hosted by the University of Toronto’s Dalla Lana School of Public Health, has received a $1.9 million investment from Canada’s COVID-19 Immunity Task Force to fund a study of COVID-19 seroprevalence across Canada.

The study aims to identify individuals who have antibodies for COVID-19 infection but may not have been tested or experienced symptoms. It focuses on specific communities and individuals that are at higher risk of infection….

https://www.utoronto.ca/news/researchers-u-t-study-presence-covid-19-antibodies-high-risk-populations

Read More Impact Stories

Posted on

Spinal cord injury: stimulating neural plasticity to improve walking

This article is only available in French. Lésion de la moelle épinière: stimuler la plasticité des neurones pour améliorer la [...]
Read more
Posted on

Unraveling the complexity of betacoronaviruses in bats

A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Read more
Posted on

Respiratory infections: better patient triage to relieve pressure on emergency departments

This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]
Read more
View All Impact Stories